Fund · First Trust Small Cap Growth AlphaDEX Fund · measured from SEC filings
FYC holdings
FYC reports 263 holdings and behaves like 214.2 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.
Measured concentration
as of 2026-07-31Read this figure with the following in mind
1.0% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 209.2
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 98.97% at a quoted market price (level 1), 8 issuer countries.
What stands out
as of 2026-07-31FYC's largest investment is Maxlinear Inc at 1.81% of net assets. Applied Optoelectronics Inc and Anaptysbio Inc follow; the three together are 3.76%. Ten companies are 7.5% of the fund; the other 253 share the rest. Among the 721 equity funds measured here, FYC behaves like 214.2 holdings against a median of 42.4 — 5.0 times the median. Across 27 quarterly filings FYC has held roughly steady since 2019-10-31 (211.2 then, 198 now). Between the 2026-01-31 and 2026-04-30 filings 111 positions were added and 111 dropped; 53.6% of the weight moved.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2019
27Between 2019-10-31 and 2026-04-30, FYC went from behaving like 211.2 equally weighted positions to 198 — 6% fewer, while its top ten went from 7.27% to 9.31% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-04-30 | 263 | 198 | 9.31% | 1.81% |
| 2026-01-31 | 263 | 204.7 | 8.25% | 0.91% |
| 2025-10-31 | 263 | 200.5 | 8.9% | 1.36% |
| 2025-07-31 | 263 | 210 | 7.75% | 0.88% |
| 2025-04-30 | 263 | 208.7 | 7.69% | 0.96% |
| 2025-01-31 | 263 | 209.8 | 7.66% | 0.86% |
| 2024-10-31 | 263 | 209.9 | 7.4% | 0.86% |
| 2024-07-31 | 263 | 212.1 | 7.26% | 0.79% |
Earlier filings (19 more, back to 2019-10-31)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-04-30 | 263 | 209.5 | 7.85% | 1.09% |
| 2024-01-31 | 262 | 210.5 | 7.4% | 0.91% |
| 2023-10-31 | 262 | 210.8 | 7.3% | 0.77% |
| 2023-07-31 | 262 | 211.7 | 7.29% | 0.93% |
| 2023-04-28 | 262 | 212 | 7.17% | 0.77% |
| 2023-01-31 | 262 | 213.4 | 7.37% | 0.86% |
| 2022-10-31 | 262 | 208.5 | 7.81% | 0.83% |
| 2022-07-29 | 262 | 213.2 | 7.32% | 0.78% |
| 2022-04-29 | 262 | 205.2 | 7.86% | 0.94% |
| 2022-01-31 | 262 | 210.8 | 7.75% | 0.88% |
| 2021-10-29 | 262 | 207.5 | 7.77% | 0.98% |
| 2021-07-30 | 262 | 211.4 | 7.23% | 0.77% |
| 2021-04-30 | 262 | 211.2 | 7.5% | 0.79% |
| 2021-01-29 | 262 | 203.4 | 8.53% | 1.11% |
| 2020-10-30 | 262 | 211.5 | 7.66% | 0.84% |
| 2020-07-31 | 262 | 206.1 | 8.07% | 1.25% |
| 2020-04-30 | 262 | 213.9 | 7.37% | 0.82% |
| 2020-01-31 | 261 | 210.2 | 7.37% | 0.89% |
| 2019-10-31 | 262 | 211.2 | 7.27% | 0.79% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
1.04% collateralFYC's filing lists 264 positions including 1.04% of net assets in securities-lending cash collateral. Counted as filed the fund reads 209.2 effective holdings with a top ten of 7.84%; on its own investments — the figure above — it reads 214.2 with a top ten of 7.5%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-04-30The 15 largest of 263 positions in FYC's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: FYC.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | MAXLINEAR INC | 1.81% | 1.8% |
| 2 | APPLIED OPTOELECTRONICS INC | 1.08% | 2.9% |
| 3 | ANAPTYSBIO INC | 0.86% | 3.8% |
| 4 | INHIBRX BIOSCIENCES INC | 0.86% | 4.6% |
| 5 | CUSTOM TRUCK ONE SOURCE INC | 0.83% | 5.4% |
| 6 | MYR GROUP INC | 0.80% | 6.2% |
| 7 | KAISER ALUMINUM CORP | 0.79% | 7.0% |
| 8 | GARRETT MOTION INC | 0.78% | 7.8% |
| 9 | BEL FUSE INC | 0.77% | 8.6% |
| 10 | ADEIA INC | 0.74% | 9.3% |
| 11 | SOLARIS ENERGY INFRASTRUCTURE INC | 0.73% | 10.0% |
| 12 | RELAY THERAPEUTICS INC | 0.72% | 10.8% |
| 13 | EZCORP INC | 0.72% | 11.5% |
| 14 | CENTURI HOLDINGS INC | 0.72% | 12.2% |
| 15 | AMPRIUS TECHNOLOGIES INC | 0.69% | 12.9% |
By country of issuer
as of 2026-04-30Share of FYC's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| United States | 96.77% |
| Cayman Islands° | 1.32% |
| Ireland° | 0.67% |
| Bahamas | 0.48% |
| British Virgin Islands° | 0.40% |
| Jersey° | 0.15% |
| Bermuda° | 0.11% |
| Netherlands° | 0.10% |
Returns the fund reported
2019-08 – 2026-04Monthly total returns from Item B.5 of FYC's own filings, 81 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference 0.12 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: FYC.json · all funds.
Who borrows FYC's shares
2026-07-31The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $13m was out to 12 borrowers. The largest, MORGAN STANLEY & CO LLC, held 26.7% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| MORGAN STANLEY & CO LLC | $3m | 26.7% |
| BARCLAYS CAPITAL INC. | $3m | 21.4% |
| BofA Securities, Inc. | $2m | 14.6% |
| Scotia Capital (USA) Inc | $1m | 8.0% |
| UBS AG | $979,418 | 7.5% |
The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter FYC has filed, with each borrower: FYC.json · all funds.
Since the previous filing
2026-01-31 → 2026-04-30263 positions became 263: 111 added (43.5% of the fund at the later date), 111 dropped (39.3% at the earlier date). Half the sum of all weight changes, a turnover proxy: 53.6%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of FYC compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-01-31 | 2026-04-30 | Largest decreases | 2026-01-31 | 2026-04-30 |
|---|---|---|---|---|---|
| REMITLY GLOBAL INC | 0.12% | 0.62% | VIRIDIAN THERAPEUTICS INC | 0.66% | 0.15% |
| IRIDIUM COMMUNICATIONS INC | 0.14% | 0.63% | CADRE HOLDINGS INC | 0.61% | 0.11% |
| APPLIED OPTOELECTRONICS INC | 0.62% | 1.08% | ACM RESEARCH INC | 0.91% | 0.43% |
| AMERICAN SUPERCONDUCTOR CORP | 0.13% | 0.52% | PROGYNY INC | 0.58% | 0.12% |
| ADEIA INC | 0.38% | 0.74% | NEWAMSTERDAM PHARMA COMPANY NV | 0.55% | 0.10% |
| CINEMARK HOLDINGS INC | 0.12% | 0.46% | WILLDAN GROUP INC | 0.75% | 0.33% |
New: MAXLINEAR INC (1.81%), ANAPTYSBIO INC (0.86%), INHIBRX BIOSCIENCES INC (0.86%), KAISER ALUMINUM CORP (0.79%), RELAY THERAPEUTICS INC (0.72%), EZCORP INC (0.72%). Gone: Vicor Corp (0.89%), Mirum Pharmaceuticals Inc (0.81%), Eos Energy Enterprises Inc (0.79%), Planet Labs PBC (0.78%), Lemonade Inc (0.75%), Tutor Perini Corp (0.73%).
Asset categories and pricing
as of 2026-07-31| Asset category (as filed) | Share of investments |
|---|---|
| equity EC | 98.92% |
| repurchase agreement RA | 1.03% |
| short-term investment STIV | 0.05% |
99.0% of FYC is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of FYC (214.2). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| INTF iShares International Equity Factor ETF | 498 | 208.5 | 12.83% | 2026-07-31 |
| IJJ iShares S&P Mid-Cap 400 Value ETF | 303 | 208.8 | 10.09% | 2026-06-30 |
| MDYV State Street(R) SPDR(R) S & P 400(TM) Mid Cap Value ETF | 302 | 209.2 | 10.07% | 2026-06-30 |
| IVOV Vanguard S&P Mid-Cap 400 Value Index Fund | 304 | 210.1 | 10.2% | 2026-05-31 |
| GSID Goldman Sachs MarketBeta International Equity ETF | 894 | 213.3 | 13.31% | 2026-05-31 |
| VEU Vanguard FTSE All-World Ex-US Index Fund | 3,890 | 216 | 14.39% | 2026-07-31 |
| VYMI Vanguard International High Dividend Yield Index Fund | 1,580 | 217.9 | 13.89% | 2026-07-31 |
| SMIN iShares MSCI India Small-Cap ETF | 475 | 220.2 | 13.3% | 2026-05-31 |
| NUSC Nuveen ESG Small-Cap ETF | 405 | 222.4 | 10.19% | 2026-07-31 |
| SPDW State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 2,444 | 227.8 | 14.04% | 2026-06-30 |
Essays that examine FYC
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.